ArticleCurrent microbiology2020
In Vitro Detoxification Studies of p-Cresol by Intestinal Bacteria Isolated from Human Feces.
Article in Current microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Synbiotic-driven modulation of the gut microbiota and metabolic functions related to obesity: insights from a human gastrointestinal model.BMC microbiology · 2025Article
- UnravelingFrontiers in pharmacology · 2025Review
- The efficacy of anti-proteolytic peptide R7I in intestinal inflammation, function, microbiota, and metabolites by multi-omics analysis in murine bacterial enteritis.Bioengineering & translational medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
p-Cresol is a neurotoxic and nephrotoxic carcinogenic aromatic substance produced as a result of microbial fermentation in the intestine. The derivatives of p-cresol (p-cresyl sulphate or p-cresyl glucuronide) have a deleterious effect on renal failure patients undergoing hemodialysis. Human gut seems to be inhabited with a diverse microbial population capable of detoxifying many aromatic compounds. However, the knowledge on the role of gut microbes in metabolizing p-cresol is limited. Hence, the present study aims to investigate p-cresol detoxification by intestinal bacteria isolated from human feces. Three potential p-cresol tolerant isolates were selected and identified as Enterococcus faecalis strains (UTD-1, UTD-2 and UTD-3) by 16SrRNA gene sequencing. All three E. faecalis isolates decreased the p-cresol concentration (30 µg/ml) at a higher rate with extracellular extracts (2.58-9.53 µg/ml) as compared to intracellular (0.55-5.28 µg/ml) extract. These three potential isolates also exhibited tolerance to gastrointestinal conditions for up to 60 min. Added to its potential, the expression of virulent genes (esp, gelE, and cyl) was found to be suppressed when subjected to bile stress under in vitro conditions. HPLC analysis displayed transformed products from extracellular extract treated samples were comparable to the metabolite standard of the p-cresol degradation pathway. Infrared spectral analysis too showed the spectrum similarity with metabolite standard. Thus, conclusively, intestinal isolates E. faecalis (UTD-1, UTD-2 and UTD-3) might be a promising candidate for mitigating p-cresol detoxification in uremic patients.
Indexed as
Identifiers
32683469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.